Trial intelligence / Profile preview

Intraoperative subanesthetic esketamine for postoperative sleep in elderly patients with preoperative sleep disorders

ChiCTR2500095523Phase 4Not yet recruiting

Sponsor
Longchang People's Hospital
Start
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in sleep disorder comparing Esketamine intraoperative infusion with Normal saline intraoperative infusion (placebo) (2 arms). Primary endpoint: Incidence of postoperative sleep disorders on postoperative day 1 and day 3. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

sleep disorder

Beyond the preview

Go deeper on ChiCTR2500095523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500095523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call